Adjuvant mitotane treatment for adrenocortical carcinoma.
暂无分享,去创建一个
M. Papotti | P. Bruzzi | M. Fassnacht | E. Arvat | W. Saeger | S. Hahner | B. Allolio | B. Ambrosi | M. Mannelli | L. Dogliotti | G. Lombardi | E. Bollito | F. Mantero | A. Berruti | P. Loli | G. Reimondo | M. Terzolo | R. Rossetto | A. Angeli | L. Tauchmanovà | P. Conton | E. Grossrubatscher | F. Daffara | P. Sperone | A. Koschker | L. Buci
[1] W. Kenn,et al. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. , 2006, The Journal of clinical endocrinology and metabolism.
[2] L. Kirschner. Emerging treatment strategies for adrenocortical carcinoma: a new hope. , 2006, The Journal of clinical endocrinology and metabolism.
[3] T. Giordano,et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. , 2005, Endocrine-related cancer.
[4] P. Casali,et al. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. , 2005, Endocrine-related cancer.
[5] M. Fassnacht,et al. Mitotane for adrenocortical carcinoma treatment. , 2005, Current opinion in investigational drugs.
[6] Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0 (CTCAE) , 2003 .
[7] C. Cordon-Cardo,et al. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] E. Baudin,et al. Impact of monitoring plasma 1,1‐dichlorodiphenildichloroethane (o,p′DDD) levels on the treatment of patients with adrenocortical carcinoma , 2001, Cancer.
[9] E. Baudin,et al. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. , 2001, Cancer research.
[10] P. Schultz,et al. Adrenocortical carcinoma , 2001, Cancer.
[11] Y. Chapuis,et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group , 2001, World Journal of Surgery.
[12] A. Kasperlik-Załuska. Clinical results of the use of mitotane for adrenocortical carcinoma. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[13] A. Latronico,et al. Adrenocortical carcinoma , 2000, Cancer.
[14] M. Brennan,et al. Long-Term Survival After Complete Resection and Repeat Resection in Patients With Adrenocortical Carcinoma , 1999, Annals of Surgical Oncology.
[15] V. Budach,et al. [Adrenal cortical carcinoma]. , 1999, Zhonghua wai ke za zhi [Chinese journal of surgery].
[16] O. Nativ,et al. Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma? , 1998, The Journal of clinical endocrinology and metabolism.
[17] F. Mosca,et al. Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. , 1997, Surgery.
[18] M. Boscaro,et al. Adrenocortical carcinoma: experience in 45 patients. , 1997, Oncology.
[19] D. Berger,et al. Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. , 1995, Surgery.
[20] A. Makowska,et al. Adrenocortical carcinoma. A clinical study and treatment results of 52 patients , 1995, Cancer.
[21] G. Fleuren,et al. Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. , 1994, British Journal of Cancer.
[22] K. Hess,et al. Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer , 1993, Cancer.
[23] K. Hess,et al. Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer , 1993, Cancer.
[24] M. Brennan,et al. An eleven-year experience with adrenocortical carcinoma. , 1992, Surgery.
[25] P Blondeau,et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. , 1990, The New England journal of medicine.
[26] L. Medeiros,et al. Pathologic Features of Prognostic Significance in Adrenocortical Carcinoma , 1989, The American journal of surgical pathology.
[27] J. Montie,et al. The Cleveland Clinic experience with adrenal cortical carcinoma. , 1989, The Journal of urology.
[28] L. Weiss. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors , 1984, The American journal of surgical pathology.
[29] P. Carpenter,et al. Adrenal cortical carcinoma--a continuing challenge. , 1983, Surgery.
[30] N. Thompson,et al. Treatment of adrenal carcinomas. , 1982, Archives of surgery.
[31] M. Boileau,et al. Adrenal cortical carcinoma. , 1978, The Journal of urology.
[32] D. A. Macfarlane. Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases. , 1958, Annals of the Royal College of Surgeons of England.